Category Archives: Industry
West Virginia University Cancer Institute is using Photobiomodulation for their Oral mucositis patients
MONONGALIA COUNTY, W.Va (WDTV) – Cancer patients deal with many side effects when they go through treatment. The WVU Cancer Institute Department of Radiation Oncology found a way to prevent a side effect, known as mucositis, that is seen in head and neck cancer patients.
“It is an inflammation type of condition from head and neck radiation,” THOR photomedicine dental and oral mucositis specialist, Sara Jane Snyder said. “They get painful sores throughout their entire oral cavity, down their esophagus and all they down through their digestive track,” she said.
“Anybody who’s getting a high dose of chemoradiation treatment, it’s almost 100 percent guarantee that their going to get a high level of oral mucositis.”
Having mucositis can make everyday tasks difficult, like eating or brushing your teeth. This is why using what is called photobiomodulation helps treat this side effect.
“What we … Continue reading
Owner Linda Bailey of Total You Health, winner of the Roanoke Regional Chamber of Commerce’s 2019 Small Business Award, did not let the pandemic stop her from delivering health to the community. In response to social distancing measures, Bailey made the decision to close her doors to human clients and take her healing equipment to the horse barn.
Total You Health has treated four horses for pain and inflammation by using their portable Photobiomodulation therapy unit with much success. Photobiomodulation, also known as “red light” therapy, is traditionally used on people in chronic pain, but this is also seen to relieve symptoms for depression, anxiety and other conditions.
Read the full article on theroanoker.com
Article and video on wsls.com
SEATTLE, Feb. 18, 2020 /PRNewswire/ — LumiThera Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular disorders and diseases, today announced it has initiated further studies with the University of Wisconsin-Milwaukee to establish the use of their Photobiomodulation platform in Diabetic Retinopathy (DR).
“Recent research in our labs in both preclinical and clinical areas have indicated potential in treating diabetic edema with PBM,” stated Janis Eells, Ph.D., Professor, University of Wisconsin-Milwaukee. “Our work shows that early PBM benefits in reducing the detrimental effects of high glucose on retinal cells and early human data is now starting to show benefits in the clinical setting.”
DR is the leading cause of blindness in the world. The International Diabetes Foundation 2019 Fact Sheet estimated that globally 463 million people have diabetes now, and future … Continue reading
Shepherd University nursing students will use light therapy to help fight the opioid epidemic.
SHEPHERDSTOWN, W.Va. (WDVM) — Shepherd University’s school of nursing hosted a photo-biomodulation therapy and wound management conference on Wednesday.
The conference discussed techniques in using light therapy to treat opioid addiction. the nursing school was recently awarded grant money from HRSA Anew, which will be used to fund studies to help find ways to fight West Virginia’s opioid crisis.
“We try to do as many things as we can to help the students to prepare to be able to treat the patients and to be able to impact the opioid epidemic at some point,” said Dr. Kelly Watson Huffer Assistant Professor at Shepherd University School of Nursing.
At the conference, students were able to practice using equipment that would be used for light therapy methods.
Dwight Heron, former director of oncology at UPMC International, co-founded REDjuvenate LLC, a company that uses photobiomodulation to treat skin problems, muscle aches and pains and other issues.
Dr. Heron, a noted radiation oncologist, said he is finishing his UPMC career with a six-month sabbatical. Dr. Heron’s center is the first in the region to use NovoTHOR equipment.
“After a few treatments, you begin seeing the effect,” Dr. Heron said about photobiomodulation therapy. “We think there’s some real opportunities here.”
Read the full article on Pittsburgh Post-Gazette
LumiThera Enrolls First Patient in the U.S. Multi-Center, LIGHTSITE III Clinical Study to Treat Dry Age-Related Macular Degeneration
SEATTLE, Oct. 1, 2019 /PRNewswire/ — LumiThera Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular disorders and disease, today announced it has begun enrolling patients in a multi-center United States clinical study in dry Age-Related Macular Degeneration (AMD) patients.
The randomized, multi-center study called LIGHTSITE III enrolled and treated the first patient at Cumberland Valley Retina in Hagerstown, Maryland. The United States study is being conducted in leading retinal centers throughout the United States. The study will enroll approximately 100 patients suffering from dry AMD and treat them over the course of two years. In addition to demonstrating safety, key efficacy endpoints include visual acuity, contrast sensitivity and reduction of drusen deposits.
In February, the company announced that the National Institute of Health and the division of the National Eye Institute was providing a $2.5M grant to partially support the U.S. study.
“This is … Continue reading
THOR Photomedicine work with leading universities and hospitals around the world, providing up to date research data and cutting edge knowledge on training courses. This 2 minute video gives you a small taste/overview of what you can expect attending our one day Photobiomodulation workshop course.
Register today for our comprehensive training and equip yourself with the tools to relieve pain.